Episode 117 | Alison Burklund, Co-Founder & CTO at Nanopath and Kate Rumrill, President and CEO at Ablative Solutions | Two Medtech Entrepreneurs: Early Stage vs. Growth Stage

In this episode, Alison Burklund, Kate Rumrill and Duane Mancini discuss their Medtech companies, comparing and contrasting raising money at a series D vs. series A, culture at a series A vs series D, coming into the CEO role vs. being a co-founder, and so much more. Alison Burklund LinkedIn Nanopath Website Kate Rumrill LinkedIn Ablative Solutions Website Project Medtech Website Duane Mancini LinkedIn Project Medtech LinkedIn